The opinion concludes that the biocidal product ‘Bioquell HPV-AQ’ is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that, subject to compliance with the draft SPC, it meets the conditions laid down in Article 19(1) of that Regulation.
Recital 5, Regulation (EU) 2022/1226
In forcesince 14 Jul 2022